We are an independent, fully-privately owned pharmaceutical company.
Our offices are in Vienna.
We acquire, develop and supply established medical products in Europe.
Acquire. Manufacture. Market.
We acquire established branded healthcare products from multinational and speciality pharmaceutical companies
Develop. Manufacture. Market.
With new formulations and new markets, we develop healthcare products in well-defined therapeutic areas
Partner
We build partnerships to expand our portfolio. We offer a nimble approach to partnering and collaboration. We have good knowledge of central European healthcare markets and access to key medical opinion leaders.
Quality
We follow and implement high standards of quality and excellence
Products
Finished Dosage Forms
Anti Infectives and Vitamins
Rokiprim
For the treatment of gram +/- infectious diseases
Rokiprim solution for infusion contains a combination of Sulfametrol and Trimethoprim. The two chemotherapeutic agents are effective against a broad range of both gram negative and gram positive microorganisms. The indications are for the treatment of infections of the urinary, gastrointestinal, respiratory and genital tract and of the skin.
Lidaprim film coated tablets, containing Sulfametrol and Trimethoprim, allow for the oral treatment of the same range of infections as Rokiprim. For more severe infections, Rokiprim should be administered.
Sulfametrole combined with trimethoprim shows bactericidal and fungicidal activity (Pneumocystis jirovecii). The spectrum of activity of the combination covers gram-positive and gram-negative microorganisms.
Simon has over 12 years of experience in pharmaceutical and healthcare management. Before that, he worked for 10 years in Investment Banking at Lehman Brothers and UBS Investment Bank (formerly S.G. Warburg) in London where he advised in senior roles on a variety of M & A and equity transactions. His sector focus included healthcare and biotechnology and the geographical focus Central and Southern Europe.
Whilst working for Medichron Simon met Gerfried Nell and decided to set up a speciality pharma business together. Simon completed his doctoral studies at the University of Cambridge (Fitzwilliam College) and obtained a Masters degree in Economics from the College of Europe in Bruges.
Gerfried Nell
Gerfried has over 30 years of experience in international pharma. Before founding Rokitan with Simon, he set up NPC Connect assisting pharmaceutical companies in medical, regulatory and market access affairs. He also acted as a senior clinical investigator. Before, Gerfried worked at Ciba-Geigy and Novartis Austria as Medical Director in charge of clinical research, registration, reimbursement, pharmacovigilance, quality assurance and medical affairs. Previously, he was with Eli Lilly (Indianapolis, USA) and Altana (Konstanz, Germany) as senior medical researcher in Clinical Pharmacology.
Gerfried was educated at the Medical University of Vienna where he received his PhD in medicine. Subsequently, he was awarded a Professorship at Saarland University and worked as senior lecturer in pharmacology. Gerfried is a senior member of IFAPP (International Federation of Associations of Pharmaceutical Physicians and Pharmaceutical Medicine).